Clik here to view.
People Living With HIV Rally in Streets of Delhi as India Hosts RCEP Trade...
Source: MSF Access Campaign Third meeting of RCEP Working Group on Intellectual Property begins New Delhi, 3 December 2014: As the 6th round of negotiations on the Regional Comprehensive Economic...
View ArticleClik here to view.
Senate Bill Offers 15 Years of Data Exclusivity for Drugs for Unmet Needs
Source: Wall Street Journal December 15,2014 A bill was introduced in the U.S. Senate late last week that would provide a drug maker with an unprecedented 15 years of data exclusivity for a medicine...
View ArticleClik here to view.
Biologics Industry Uses Political Power to Retain Monopoly, Price-Gouge and...
Source: Public Citizen Biologics Industry Uses Political Power to Retain Monopoly, Price-Gouge and Limit Patient Access to Needed Medications New Report Shows the Future of Medicine Could Be Extremely...
View ArticleClik here to view.
Study Claims U.S. TPP Proposal Would Cut In Half Access To HIV Drugs In Vietnam
Source: Inside U.S. Trade 6 Jan 2015 Access to anti-retroviral drugs used to treat HIV would be roughly cut in half in Vietnam if the provisions in the current U.S. proposal on intellectual property...
View ArticleClik here to view.
Recent Development on US pressure on Indian Patent Law
Source: IP Health, 4 Feb 2015 Michael Froman testified in a Congressional hearing on 27 January 2015 that the USTR has secured “commitments from India in the 2014 Trade Policy Forum on a broad range...
View ArticleClik here to view.
RCEP Negotiations l 7th Round l Asia-Pacific Health Groups Raise concerns...
Asia-Pacific Health Groups Raise concerns over intellectual property and investment provisions in RCEP negotiations Call on RCEP countries to protect public health and access to medicines as 7th...
View ArticleClik here to view.
DNP+ response to RCEP negotiations on Intellectual Property ongoing in Thailand
The seventh round of negotiations on the Regional Comprehensive Economic Partnership (RCEP) trade agreement have kick started in Thailand yesterday. Started in May 2013, the RCEP is being negotiated...
View ArticleClik here to view.
Opinion: Prof Brook K Baker on the impact of US pressure to change India’s IP...
Source: Express Pharma 12 Feb 2015 Will a new US-led IP empire in India put access to medicines at risk? Prof Brook K Baker, Professor of Law, Northeastern University, cautions that the Modi...
View ArticleClik here to view.
Free Trade Makes Cancer Drugs Cheaper
Source: Bloomberg View 19 Feb 2015 CHEAPER BY THE DOZEN. PHOTOGRAPHER: KELVIN MA/BLOOMBERG Some parents of children with attention deficit disorder got a welcome surprise last month. If they went to...
View ArticleClik here to view.
Will a new US-led IP empire in India put access to medicines at risk?
Source: Financial Express 26 Feb 2015 Prof Brook K Baker, Professor of Law and Northeastern University, cautions that the Modi government’s accelerating flirtation with the US and its investors is...
View ArticleClik here to view.
A bitter pill for pharma units
Source: Hindu Business Line , 3 May 2015 The thriving Indian generic pharmaceutical industry has, over the past decade, earned its stripes globally as a source of reliable and cheap generic versions of...
View ArticleClik here to view.
How Marketing Exclusivity Led to Higher Drug Costs and Questionable Benefits
Source- Wall Street Journal Pharmalot, 6 May, 2015 Six years ago, the FDA approved a drug called Colcrys to treat acute gout attacks and familial Mediterranean fever, an inherited inflammatory...
View ArticleClik here to view.
Data exclusivity back on the table for India
Source : Spicy IP, March 27, 2015 D.G. Shah, Secretary General of the Indian Pharmaceutical Alliance sends us news that will be of interest to many of our readers. He says, “… Government plans to...
View ArticleClik here to view.
Decision Time On Biologics Exclusivity: Eight Years Is No Compromise
Source: IP Watch 30 July 2015 As the Trans-Pacific Partnership (TPP) negotiations approach their endgame, biologics exclusivity is still considered “one of the most difficult outstanding issues in the...
View ArticleClik here to view.
Will America’s Drug Lobby Destroy the TPP?
Source: The National Interest 18 Aug 2015 “Unfortunately, the United States seems determined to complicate this important work with petty, unreasonable demands for pharmaceutical protections.” For all...
View Article